Dittner-Moormann, S. Et Al. 2021. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). PEDIATRIC BLOOD & CANCER , vol.68, no.6 .

Dittner-Moormann, S., Reschke, M., Abbink, F. C. H., Aerts, I., ATALAY, H. T., Fedorovna Bobrova, N., ... Biewald, E.(2021). Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). PEDIATRIC BLOOD & CANCER , vol.68, no.6.

Dittner-Moormann, Sabine Et Al. "Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)," PEDIATRIC BLOOD & CANCER , vol.68, no.6, 2021

Dittner-Moormann, Sabine Et Al. "Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)." PEDIATRIC BLOOD & CANCER , vol.68, no.6, 2021

Dittner-Moormann, S. Et Al. (2021) . "Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)." PEDIATRIC BLOOD & CANCER , vol.68, no.6.

@article{article, author={Sabine Dittner-Moormann Et Al. }, title={Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)}, journal={PEDIATRIC BLOOD & CANCER}, year=2021}